Lower Out of Pocket Insulin Costs for U.S. Medicare's Seniors
Across America, 88 Part D Sponsors applied to the Part D Senior Savings Model to offer enhanced plans with a maximum $35 copay for a broad set of insulins beginning in 2021 (Source: Disabled World)
Source: Disabled World - May 26, 2020 Category: Disability Tags: U.S. Medicare Source Type: news

Lower Out of Pocket Insulin Costs for U.S. Medicare Seniors
Across America, 88 Part D Sponsors applied to the Part D Senior Savings Model to offer enhanced plans with a maximum $35 copay for a broad set of insulins beginning in 2021 (Source: Disabled World)
Source: Disabled World - May 26, 2020 Category: Disability Tags: U.S. Medicare Source Type: news

Type 2 diabetes warning: The frightening sign your blood sugar levels are dangerously high
TYPE 2 diabetes means the body doesn't use insulin properly - a hormone which regulates a person's blood sugar levels. Without proper treatment, toxic amounts of sugar can build up in the bloodstream, wreaking havoc from head to toe. Hypercoagulability often occurs due to this, but what is it? (Source: Daily Express - Health)
Source: Daily Express - Health - May 26, 2020 Category: Consumer Health News Source Type: news

IGF-1 receptor activity in the Golgi of migratory cancer cells depends on adhesion-dependent phosphorylation of Tyr1250 and Tyr1251
Although insulin-like growth factor 1 (IGF-1) signaling promotes tumor growth and cancer progression, therapies that target the IGF-1 receptor (IGF-1R) have shown poor clinical efficacy. To address IGF-1R activity in cancer cells and how it differs from that of the closely related insulin receptor (IR), we focused on two tyrosines in the IGF-1R C-terminal tail that are not present in the IR and are essential for IGF-1–mediated cancer cell survival, migration, and tumorigenic growth. We found that Tyr1250 and Tyr1251 (Tyr1250/1251) were autophosphorylated in a cell adhesion–dependent manner. To investigate the c...
Source: Signal Transduction Knowledge Environment - May 26, 2020 Category: Science Authors: Rieger, L., OShea, S., Godsmark, G., Stanicka, J., Kelly, G., OConnor, R. Tags: STKE Research Articles Source Type: news

The tale of a tail: The secret behind IGF-1Rs oncogenic power
The C-terminal tail of insulin-like growth factor 1 receptor (IGF-1R) has long been appreciated to drive much of this receptor’s oncogenic power. In this issue of Science Signaling, Rieger et al. have shown that Tyr1250 and Tyr1251 of IGF-1R are autophosphorylated in a cell adhesion–dependent manner, uncovering a previously unknown plasma membrane–Golgi trafficking route for IGF-1R in migratory cells, an integral part of the malignant phenotype. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - May 26, 2020 Category: Science Authors: Crudden, C., Girnita, L. Tags: STKE Focus Source Type: news

How Long Does Neonatal Galactorrhea Last?
Discussion Galactorrhea is a milky discharge from the breast in a non-lactating female. Neonatal galactorrhea is sometimes called “Witch’s Milk” based on ideas from the 17th century or earlier that witches would steal the milk for use in their magic. Infant breasts were often compressed to express the fluid and prevent its collection. During the 19th century, reports of breast inflammation and even abscess were reported because of this practice and it was strongly discouraged, and continues to not be recommended today. Enlargement of neonatal breasts and galactorrhea, both for males and females, is fel...
Source: PediatricEducation.org - May 25, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

NHS expands offer of help to people with diabetes during coronavirus outbreak, NHS England
NHS England has called on people with diabetes to access help available to them, including a new dedicated helpline, together with Diabetes UK, Novo Nordisk and Insulet, to advise those who need help with insulin, as well as online tools to help manage condition during outbreak. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 22, 2020 Category: Consumer Health News Source Type: news

Age, CRP Up Risk for Mortality in Diabetes With COVID - 19
Insulin usage linked to poor prognosis; ACEI/ARB use did not impact clinical outcome in those with HTN (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 20, 2020 Category: Respiratory Medicine Tags: Endocrinology, Family Medicine, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pharmacy, Pulmonology, Journal, Source Type: news

Age, CRP Up Risk for Mortality in Diabetes With COVID-19
WEDNESDAY, May 20, 2020 -- For patients with diabetes and COVID-19, risk factors for mortality include older age and elevated C-reactive protein, and insulin usage is associated with poor prognosis, according to a study published online May 14 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 20, 2020 Category: Pharmaceuticals Source Type: news

Insulin Resistance May Contribute to Worse Prognosis in Black Women with Breast Cancer
Insulin resistance was found to be 1 factor that contributes to the worse prognosis in breast cancer between black and white women, potentially through direct effects of insulin on the tumor insulin receptor. (Source: CancerNetwork)
Source: CancerNetwork - May 16, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Strategies to Overcome Psychological Insulin Resistance Strategies to Overcome Psychological Insulin Resistance
Many patients with type 2 diabetes are initially reluctant to begin insulin. What strategies can health care providers use to help patients overcome this psychological resistance?Journal of the American Board of Family Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 12, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Insulins available at US pharmacies are consistent with product labeling
(JDRF) Funding partners JDRF, the American Diabetes Association (ADA), and The Leona M. and Harry B. Helmsley Charitable Trust, in partnership with the University of Florida, announce the results of a study examining the consistency and potency of insulin purchased at U.S. retail pharmacies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2020 Category: International Medicine & Public Health Source Type: news

Experimental two-in-one shot may give diabetics a better way to control their blood sugar
(Stanford School of Engineering) Amylin plays a synergistic role with insulin to control blood sugar levels after eating in a way that is more effective than insulin alone and mimics what occurs naturally with a meal. But until now the two hormones - which work together seamlessly in the body - have been too unstable to coexist in the same syringe. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 11, 2020 Category: Biology Source Type: news

Insulin resistance contributes to racial disparities in breast cancer prognosis in US women, Mount Sinai researchers reveal
(The Mount Sinai Hospital / Mount Sinai School of Medicine) New study identifies that differences in insulin resistance can explain in part the disparities in breast cancer survival between black and white women. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2020 Category: Cancer & Oncology Source Type: news

States grant nurse practitioners full practice authority
As a nurse practitioner in Charlotte, North Carolina, Olivia Garcia can prescribe injectable insulin to treat a patient ’s diabetes, but she is not allowed to write that same patient a prescription for diabetic shoes. Such are the limitations that NPs work under in 28 states that limit practice authority for nurse practitioners. Instead, NPs in those states must work with an overseeing physician. But amid the Cov id-19 pandemic and a shortage of primary care physicians, multiple states have taken… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 9, 2020 Category: Biotechnology Authors: Laura Williams-Tracy Source Type: news

States grant nurse practitioners full practice authority
As a nurse practitioner in Charlotte, North Carolina, Olivia Garcia can prescribe injectable insulin to treat a patient ’s diabetes, but she is not allowed to write that same patient a prescription for diabetic shoes. Such are the limitations that NPs work under in 28 states that limit practice authority for nurse practitioners. Instead, NPs in those states must work with an overseeing physician. But amid the Cov id-19 pandemic and a shortage of primary care physicians, multiple states have taken… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 9, 2020 Category: Pharmaceuticals Authors: Laura Williams-Tracy Source Type: news

States grant nurse practitioners full practice authority
As a nurse practitioner in Charlotte, North Carolina, Olivia Garcia can prescribe injectable insulin to treat a patient ’s diabetes, but she is not allowed to write that same patient a prescription for diabetic shoes. Such are the limitations that NPs work under in 28 states that limit practice authority for nurse practitioners. Instead, NPs in those states must work with an overseeing physician. But amid the Co vid-19 pandemic and a shortage of primary care physicians, a number of states have… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 7, 2020 Category: Biotechnology Authors: Laura Williams-Tracy Source Type: news

More Guidance on Inpatient Management of Blood Glucose in COVID-19
Two new graphics from Diabetes UK's COVID-19 task force address inpatient use of subcutaneous insulin for managing hyperglycemia and ketoacidosis when intravenous equipment is unavailable. (Source: WebMD Health)
Source: WebMD Health - May 6, 2020 Category: Consumer Health News Source Type: news

More Guidance on Inpatient Management of Blood Glucose in COVID-19 More Guidance on Inpatient Management of Blood Glucose in COVID-19
Two new graphics from Diabetes UK's COVID-19 task force address inpatient use of subcutaneous insulin for managing hyperglycemia and ketoacidosis when intravenous equipment is unavailable.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - May 5, 2020 Category: Emergency Medicine Tags: Diabetes & Endocrinology News Source Type: news

Sanofi's Biosimilar Insulin Aspart Gets Green Light in EU Sanofi's Biosimilar Insulin Aspart Gets Green Light in EU
Biosimilar of fast-acting mealtime insulin aspart is given positive opinion by CHMP.International Approvals (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 5, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news

Boosting levels of good fats with an experimental drug that acts on two newly characterized genes
(Salk Institute) A team of scientists have identified two genes that can regulate levels of healthy fats, called FAHFAs, in mice. They found that the loss of the two genes led to higher-than-normal levels of the beneficial FAHFAs, while blocking the genes' activity with an experimental drug also increased FAHFA levels. Because FAHFAs decrease inflammation and increase insulin sensitivity, a better understanding of the activity of their regulatory genes may eventually lead to therapies for people with diabetes and inflammation. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 1, 2020 Category: Biology Source Type: news

Dexcom Patients Will Have Longer Wait for G7 as COVID-19 Disrupts Pivotal Trial
COVID-19 is creating much uncertainty across the medical device industry, both in terms of revenue guidance and in terms of clinical trial timing. For Dexcom, that uncertainty will directly impact the timing of the company's latest continuous glucose monitoring (CGM) sensor, the G7. "We remain confident in our ability to deliver G7, but acknowledge that the timing of the pivotal trial will be delayed due to the pausing of new trials at most clinical sites," Dexcom CEO Kevin Sayer said during the company's first-quarter earnings call, according to SeekingAlpha transcripts. Sayer said the company currently expects ...
Source: MDDI - April 30, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: COVID-19 Business Source Type: news

C-Path receives letter of support from EMA on type 1 diabetes biomarker initiative
(Critical Path Institute (C-Path)) The Critical Path Institute today announced that its Type 1 Diabetes (T1D) Consortium has received a letter of support from the European Medicines Agency to facilitate the development and validation of the proposed regulatory qualification of pancreatic islet autoantibodies commonly used in clinical practice to diagnose T1D: insulin autoantibodies, glutamic acid decarboxylase 65, and insulinoma antigen-2 autoantibodies as enrichment biomarkers for T1D clinical trials. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 28, 2020 Category: International Medicine & Public Health Source Type: news

Beta cells from stem cells
(Helmholtz Zentrum M ü nchen - German Research Center for Environmental Health) The loss of insulin-secreting beta cells by autoimmune destruction leads to type 1 diabetes. Clinical islet cell transplantation has the potential to cure diabetes, but donor pancreases are rare. In a new study, a group of researchers developed an improved pluripotent stem cell differentiation protocol to generate beta cells in vitro with superior glucose response and insulin secretion. This is a major step towards beta cell replacement therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 27, 2020 Category: International Medicine & Public Health Source Type: news

Unemployed dad says he'll sacrifice his insulin to feed his kids
Chris Jump was laid off as an aircraft mechanic weeks before the coronavirus shut down much of the economy. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - April 25, 2020 Category: Consumer Health News Source Type: news

Laid-off aerospace workers share their heartbreaking stories
CBS News followed four Kansas aerospace workers who were laid off when Boeing suspended production of the 737 Max jet, with their job hunt only growing more difficult after the coronavirus pandemic hit. One man who spoke to Kris Van Cleave said his situation was so dire that he may have to choose between insulin to treat his diabetes and food for his children. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - April 24, 2020 Category: Consumer Health News Source Type: news

Unemployed dad says he'll sacrifice his insulin to feed his kids
Chris Jump was laid off as an aircraft mechanic weeks before the coronavirus shut down much of the economy. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - April 24, 2020 Category: Consumer Health News Source Type: news

Brain insulin sensitivity determines body weight and fat distribution
(Deutsches Zentrum fuer Diabetesforschung DZD) Just where fat is deposited in the body and to what degree a person may benefit from a lifestyle intervention depends on how sensitive the brain is to insulin. If the person's brain responds sensitively to the hormone, a significant amount of weight can be lost and unhealthy visceral fat. People with brain insulin resistance only showed a slight weight loss. These are the results of a long-term study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 24, 2020 Category: International Medicine & Public Health Source Type: news

Dietary counselling introduced in infancy leads to better cardiovascular health in adults
(University of Turku) The Special Turku Coronary Risk Factor Intervention Project investigated the long-term effects of dietary counselling on cardiovascular health. The individuals, who had participated in the trial between ages 7 months and 20 years, were invited to a follow-up study at the age of 26. The results show that the intervention group who received dietary counselling had lower serum cholesterol level and better insulin sensitivity than those in the control group. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 23, 2020 Category: Biology Source Type: news

Second lawsuit filed in West Virginia VA hospital deaths
A woman is suing the federal government over the 2018 death of her husband from a wrongful insulin injection at a West Virginia veterans hospital (Source: ABC News: Health)
Source: ABC News: Health - April 22, 2020 Category: Consumer Health News Tags: Health Source Type: news

Small rises in blood glucose trigger big changes in insulin-producing cells
This study provides a wealth of new data showing how beta cells behave at slightly raised levels of blood glucose -- still within the pre-diabetes range. The work provides major additional evidence of a 'glucose toxicity' effect that helps to drive the development of both type 1 and type 2 diabetes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 21, 2020 Category: International Medicine & Public Health Source Type: news

Saliva Used to Monitor Glucose Levels?
Can saliva be used to monitor diabetes? Researchers are aiming to find out as they have developed a test that can be used as an alternative to the practice of monitoring blood glucose. The research was published in the journal PLOS ONE and involved partners at the Federal University of Uberlandia in Minas Gerais, Brazil, the University of Vale do Paraíba in Sao Paolo, Brazil and the University of Saskatchewan in Canada. Researchers said the lab tests used a scientific system known as Attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy. This has been used in the diagnosis of several d...
Source: MDDI - April 18, 2020 Category: Medical Devices Authors: MDDI Staff Tags: R & D Source Type: news

An insulin maker will give free insulin to diabetes patients whose jobs were affected by the coronavirus pandemic
One insulin maker is trying to alleviate the financial strain that people are experiencing due to the coronavirus pandemic. (Source: CNN.com - Health)
Source: CNN.com - Health - April 17, 2020 Category: Consumer Health News Source Type: news

Minnesota Governor Signs Emergency Insulin Law Minnesota Governor Signs Emergency Insulin Law
In addition, nine states have now enacted insulin copay caps.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 16, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Lost insurance & need insulin? Makers offer it free or cheap
The top three insulin makers are offering programs to help patients stay on the medicine, providing insulin for free or at steep discounts (Source: ABC News: Health)
Source: ABC News: Health - April 14, 2020 Category: Consumer Health News Tags: Health Source Type: news

It & #039;s Not Just Diabetes Patients Who Need Glucose Monitoring During This Pandemic
As reported last week, FDA is allowing both Dexcom and Abbott to supply continuous glucose monitoring (CGM) systems for use in the hospital setting during the coronavirus pandemic. This allows frontline healthcare workers in hospitals to remotely monitor patients' glucose levels while minimizing exposure to the virus that causes COVID-19 and preserving use of personal protective equipment. Dexcom CEO Kevin Sayer said the company had conversations with healthcare providers in Europe about the need for CGM technology for COVID-19 patients and the company started conversations w...
Source: MDDI - April 14, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: COVID-19 Source Type: news

Type 2 diabetes: The major warning in your feet due to blood sugar levels being too high
TYPE 2 diabetes is a condition where the insulin the pancreas makes can't work properly creating dire effects to one's health. Noticing this problem in your foot could be a warning sign that you're at risk of developing the dangerous condition. (Source: Daily Express - Health)
Source: Daily Express - Health - April 12, 2020 Category: Consumer Health News Source Type: news

Advances in neuropathologic research of hypoglycemic brain damage caused by insulin overdose - Tong F, Yang Y, Liang Y, Lopsong TZ, Liu YL, Zhao SQ, He GL, Zhou YW.
The number of death from insulin overdose, including accidental poisoning, suicide and homicide, is increasing these years. The forensic diagnosis of death from insulin overdose is a tough task. Glucose is the main energy source of the brain. Therefore, hy... (Source: SafetyLit)
Source: SafetyLit - April 9, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Eli Lilly Lowers Insulin Costs as Coronavirus Crisis Deepens Eli Lilly Lowers Insulin Costs as Coronavirus Crisis Deepens
Drugmaker Eli Lilly& Co said on Tuesday it has capped the out-of-pocket cost for insulin to $35 per month to help diabetes patients across the United States, many of whom are facing financial difficulties due to the coronavirus outbreak.Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 9, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

How Continuous Glucose Monitoring Systems Are Joining the COVID-19 Fight
In response to healthcare workers asking for safer ways to monitor hospitalized diabetes patients with COVID-19, FDA is allowing both Dexcom and Abbott to supply continuous glucose monitoring (CGM) systems for use in the hospital setting during the pandemic. This allows frontline healthcare workers in hospitals to remotely monitor patients with diabetes in order to minimize exposure to the virus that causes COVID-19 and preserve use of personal protective equipment (PPE). Abbott said it has partnered with the American Diabetes Association, Insulin for Life USA, and the Diabetes Disaster Response Coa...
Source: MDDI - April 8, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: COVID-19 Source Type: news

Patch Pump Device Could Offer Cheaper Insulin Delivery
Title: Patch Pump Device Could Offer Cheaper Insulin DeliveryCategory: Health NewsCreated: 4/1/2020 12:00:00 AMLast Editorial Review: 4/2/2020 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - April 2, 2020 Category: Endocrinology Source Type: news

Type 2 diabetes: Six dinner ideas to help lower blood sugar levels
TYPE 2 diabetes occurs when a person isn't able to produce enough insulin to function correctly. If one is living with the condition, certain changes in lifestyle need to take place, often causing worry and confusion. What are five of the best dinner choices for type 2 diabetes? (Source: Daily Express - Health)
Source: Daily Express - Health - April 1, 2020 Category: Consumer Health News Source Type: news

ENDO: Glycemic Control Good for Regular Human Insulin With V-Go
WEDNESDAY, April 1, 2020 -- For patients with type 2 diabetes (T2D), glycemic control is similar with use of regular human insulin (RHI) and rapid-acting insulin (RAI) when delivered with a wearable insulin delivery device, V-Go, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2020 Category: Pharmaceuticals Source Type: news

Patch Pump Device Could Offer Cheaper Insulin Delivery
WEDNESDAY, April 1, 2020 -- Rising prices have grabbed headlines as people struggle to afford their lifesaving insulin, but new research may have found an alternative for people with type 2 diabetes. The study found that combining a wearable,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 1, 2020 Category: General Medicine Source Type: news

Biocon says probe on Malaysia manufacturing unit ends
“This is to inform you that Biocon Sdn Bhd, a subsidiary of Biocon, has received the EIR from the USFDA for the pre-approval inspection of its insulins manufacturing facility in Malaysia, for Insulin Glargine. The inspection was conducted between Feb 10 and 21, 2020,” said the company spokespers on in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 1, 2020 Category: Pharmaceuticals Source Type: news

Type 2 diabetes: Curry spice to add to foods to lower blood sugar
TYPE 2 diabetes is an extremely common and serious problem faced by many worldwide. The condition affects insulin in the body, and this affects the pancreas. Thankfully, adding this delicious spice to your meals could greatly help to lower blood sugar and keep you healthy. (Source: Daily Express - Health)
Source: Daily Express - Health - March 31, 2020 Category: Consumer Health News Source Type: news

ENDO: Real-World Data Analyzed for Use of Insulin Pump in T1DM
TUESDAY, March 31, 2020 -- Real-world data support the benefit of using the Medtronic MiniMed 670G insulin pump system for glycemic control in type 1 diabetes, according to a study presented at the virtual meeting of The Endocrine Society, held from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 31, 2020 Category: Pharmaceuticals Source Type: news

Doctors Describe First Drone Delivery of Diabetes Meds to Patient
MONDAY, March 30, 2020 -- Imagine needing insulin to live but a natural disaster suddenly cuts off access to your medication. New drone technology may one day come to the rescue by making urgent deliveries to remote locations, researchers say. The... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 30, 2020 Category: General Medicine Source Type: news

New therapeutic strategy against diabetes
(Universitat Autonoma de Barcelona) A study by the CIBERDEM and the UAB demonstrates that high vitamin D receptor levels in pancreaticβ cells improve resistance to diabetes. The research suggests that the maintenance of the vitamin D receptor expression could be a new therapeutic strategy to counteract insulin-producing pancreatic cell damage and protect against the development of diabetes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 26, 2020 Category: International Medicine & Public Health Source Type: news

FDA: Insulin Among Drugs Transitioned to Biological Products
TUESDAY, March 24, 2020 -- Insulin and other biologic drugs, such as human growth hormone, have now transitioned to being regulated as biological products, providing a new pathway for approval of biosimilars and interchangeable versions of these... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 24, 2020 Category: Pharmaceuticals Source Type: news